For women
sun protection (UPF 50+) and are guaranteed for life not to wear out.
For men
Botox®: Myths and Facts
MYTH #1
BOTOX COSMETIC® is unsafe.
FACT
While most commonly known as a wrinkle treatment, BOTOX® has been available in Canada for over 22 years for the effective treatment of a range of medical conditions. BOTOX COSMETIC® has been available for more than 10 years for aesthetic use. It has a well-established safety record and is one of the most widely researched medicines in the world.1-4
It is reassuring to know an estimated 29 million treatment sessions have been performed worldwide over the past 20 years (1990-2010).5 In addition, BOTOX COSMETIC® has received a 95% satisfaction rating among users.6
Please ask Dr. Chiasson or any member of our medical team about any serious or non-serious side effects that you may experience with use.
MYTH #2
BOTOX COSMETIC® will result in the loss of facial expression.
FACT
It is intended to enhance the way you look, not change it. When administered by one of Figurra's experienced medical team member, the treatment is designed to produce a more natural and relaxed appearance.7
The treatment only relaxes the muscle beneath the lines at the point of injection, so the other elements of facial expression remain active.3
MYTH #3
BOTOX COSMETIC® is botulism (food poisoning).
FACT
It is not botulism. It is a purified protein and a finished medical prescription product with a known or proven safety profile obtained through extensive research and testing. 3,4,8
MYTH #4
BOTOX COSMETIC® treatment is painful.
FACT
A treatment is quick and simple.5 A very fine needle and small amount of liquid is used so the pain associated with the injection is minimal.3 A topical anaesthetic can be used to reduce any discomfort you may experience.
MYTH #5
Injections can be given anywhere.
FACT
BOTOX COSMETIC® is a technique-sensitive procedure. Make sure to visit a well-trained aesthetic-specialty physician for your treatment, and discuss the optimal results you would like to achieve. A treatment should only be administered in appropriate medical settings by a licensed healthcare professional.3
MYTH #6
BOTOX COSMETIC® is expensive.
FACT
The cost of BOTOX COSMETIC® varies depending on the amount of product needed to achieve optimal results and the areas of the face that are being treated. As an example, BOTOX COSMETIC® typically ranges from $300 to $500 to treat the frown lines between the eyebrows. Since the effects of a treatment can last up to four months,3 the cost is about $3-$5 per day.
MYTH #7
There are creams that are better than BOTOX COSMETIC®.
FACT
There is no scientific evidence that supports that creams work better. Creams work well on the surface of the skin. BOTOX COSMETIC® works below the surface of the skin to relax the muscles that cause lines and wrinkles to form.3
MYTH #8
BOTOX COSMETIC® is a facial filler.
FACT
Unlike facial fillers, it doesn’t fill in facial lines or restore volume loss. It relaxes the muscle underneath the skin that cause the lines.3,7 Facial fillers like JUVÉDERM® help to fill in facial lines and give back volume that is lost over time.7
MYTH #9
BOTOX COSMETIC® and BOTOX® are the same
FACT
While both products contain the same active ingredient and the same formulation, there are different uses for each.2,3 BOTOX® is used for the treatment of serious medical conditions, while BOTOX COSMETIC® is used in much smaller dosages for the treatment of facial wrinkles and lines.2,3
1. Carruthers J. and Carruthers A. Botulinum toxin in facial rejuvenation: an update. Obstetrics and Gynecology Clinics of North America. 2010; 37:571-582.
2. BOTOX® Product Monograph. Allergan, Inc. October 25, 2011.
3. BOTOX COSMETIC® Product Monograph. Allergan, Inc. October 25, 2011
4. Lowe NJ. Overview of botulinum neurotoxins. Journal of Cosmetic and Laser Therapy. 2007; 9(suppl 1):11-16.
5. Allergan Data on File. Global Regulatory Affairs.
6. Stotland MA, Kowalski JW, Ray BB. Patient-reported benefit and satisfaction with botulinum toxin type A treatment of moderate to severe glabellar rhytides: results from a prospective open-label study. Plastic and Reconstructive Surgery: 2007; 120:1386-1393.
7. Carruthers A. and Carruthers J. A single-center, dose-comparison, pilot study of botulinum neurotoxin type A in female patients with upper facial rhytids: safety and efficacy. Journal of the American Academy of Dermatology. 2009; 60:972-979.
8. Carruthers A. and Carruthers J. Long-term safety review of subjects treated with botulinum toxin type A for cosmetic use. Presented at the American Academy of Dermatology meeting. July 21-August 1, 2004.
 |
 |
 |
 |
